31. Letter: Brain Invasion in Meningiomas—Sex-Associated Differences are not Related to Estrogen- and Progesterone Receptor Expression. Issue 2 (1st August 2017) Authors: Heß, Katharina; Spille, Dorothee Cäcilia; Wagner, Andrea; Stummer, Walter; Paulus, Werner; Brokinkel, Benjamin Journal: Neurosurgery Issue: Volume 81:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Letter: Parasagittal/Falcine Tumor Location Strongly Predicts Human Telomerase Reverse Transcriptase Promoter Mutations in High-Grade Meningiomas. Issue 3 (3rd December 2019) Authors: Peetz-Dienhart, Susanne; Spille, Dorothee Cäcilia; Sporns, Peter B; Adeli, Alborz; Bunk, Eva Christine; Wagner, Andrea; Paulus, Werner; Stummer, Walter; Hess, Katharina; Brokinkel, Benjamin Journal: Neurosurgery Issue: Volume 86:Issue 3(2020) Page Start: E362 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Letter: Parasagittal/Falcine Tumor Location Strongly Predicts Human Telomerase Reverse Transcriptase Promoter Mutations in High‐Grade Meningiomas. Issue 3 (March 2020) Authors: Peetz‐Dienhart, Susanne; Spille, Dorothee Cäcilia; Sporns, Peter B; Adeli, Alborz; Bunk, Eva Christine; Wagner, Andrea; Paulus, Werner; Stummer, Walter; Hess, Katharina; Brokinkel, Benjamin Journal: Neurosurgery Issue: Volume 86:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Letter: Retention of ATRX and DAXX Expression in Meningiomas. Issue 2 (1st August 2017) Authors: Fürtjes, Gina; Heß, Katharina; Wagner, Andrea; Senner, Volker; Brokinkel, Caroline; Stummer, Walter; Brokinkel, Benjamin Journal: Neurosurgery Issue: Volume 81:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial. Issue 10172 (16th February 2019) Authors: Herrlinger, Ulrich; Tzaridis, Theophilos; Mack, Frederic; Steinbach, Joachim Peter; Schlegel, Uwe; Sabel, Michael; Hau, Peter; Kortmann, Rolf-Dieter; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Schnell, Oliver; Bähr, Oliver; Uhl, Martin; Seidel, Clemens; Tabatabai, Ghazaleh; Kowalski, Tho... Journal: Lancet Issue: Volume 393:Issue 10172(2019) Page Start: 678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). Issue 3 (21st August 2017) Authors: Beier, Dagmar; Proescholdt, Martin; Reinert, Christiane; Pietsch, Torsten; Jones, David T W; Pfister, Stefan M; Hattingen, Elke; Seidel, Clemens; Dirven, Linda; Luerding, Ralf; Reijneveld, Jaap; Warmuth-Metz, Monika; Bonsanto, Matteo; Bremer, Michael; Combs, Stephanie E; Rieken, Stefan; Herrlinge... Journal: Neuro-oncology Issue: Volume 20:Issue 3(2018) Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Multimodal Imaging of Patients With Gliomas Confirms 11C-MET PET as a Complementary Marker to MRI for Noninvasive Tumor Grading and Intraindividual Follow-Up After Therapy. (24th January 2017) Authors: Laukamp, Kai R.; Lindemann, Florian; Weckesser, Matthias; Hesselmann, Volker; Ligges, Sandra; Wölfer, Johannes; Jeibmann, Astrid; Zinnhardt, Bastian; Viel, Thomas; Schäfers, Michael; Paulus, Werner; Stummer, Walter; Schober, Otmar; Jacobs, Andreas H. Journal: Molecular imaging Issue: Volume 16(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. NIMG-32. POSTPROGRESSION SURVIVAL AND MRI FEATURES AT PROGRESSION IN MGMT-METHYLATED GLIOBLASTOMA FOLLOWING TEMOZOLOMIDE (TMZ) OR CCNU/TMZ THERAPY - AN ANALYSIS OF THE CETEG/NOA-09-TRIAL. (14th November 2022) Authors: Zeyen, Thomas; Paech, Daniel; Weller, Johannes; Schäfer, Niklas; Tzaridis, Theophilos; Duffy, Cathrina; Nitsch, Louisa; Schneider, Matthias; Steinbach, Joachim; Hau, Peter; Schlegel, Uwe; Seidel, Clemens; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Zeiner, Pia; Tabatabai, Ghazaleh; Galldi... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. QOLP-20. QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA. (5th November 2018) Authors: Weller, Johannes; Tzaridis, Theophilos; Steinbach, Joachim; Schlegel, Uwe; Hau, Peter; Krex, Dietmar; Grauer, Oliver; Goldbrunner, Roland; Bähr, Oliver; Uhl, Martin; Seidel, Clemens; Tabatabai, Ghazaleh; Bullinger, Lars; Galldiks, Norbert; Schaub, Christina; Stummer, Walter; Simon, Matthias; Fimm... Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Quality of life in the GLARIUS trial randomizing bevacizumab/irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. Issue 7 (7th November 2017) Authors: Schäfer, Niklas; Proescholdt, Martin; Steinbach, Joachim P; Weyerbrock, Astrid; Hau, Peter; Grauer, Oliver; Goldbrunner, Roland; Friedrich, Franziska; Rohde, Veit; Ringel, Florian; Schlegel, Uwe; Sabel, Michael; Ronellenfitsch, Michael W; Uhl, Martin; Grau, Stefan; Hänel, Mathias; Schnell, Oliver... Journal: Neuro-oncology Issue: Volume 20:Issue 7(2018) Page Start: 975 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗